ArticleThe Journal of clinical investigation2025

RCC2 and CD24 cooperate to modulate prostate cancer progression through vimentin ubiquitination and β-catenin activation.

Xuelian Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.